Clinical Trial Backgrounds, Marvin Update, News

13 December 2024

By Sabine Birkner

EvidentIQ Launches Marvin AI Assistant

EvidentIQ Germany is proud to announce the release of a groundbreaking feature in Marvin Version 3.0.17: The Marvin AI Assistant. This innovative AI assistant is exclusively available to Marvin studies and offers tailored support for study management, saving users significant time and effort.

The Marvin AI Assistant is designed to cater to a wide range of users—from experienced professionals with study setup questions to newcomers at the sites seeking guidance on how to operate within Marvin EDC.

Key features of the Marvin Chatbot:

  • Support for Complex and Simple Queries: Efficiently guides users through study designs and documentation.
  • Time-Saving: Delivers direct, actionable answers, eliminating the need to sift through extensive docs.
  • EU AI Act Compliance: Marvin is one of the first AI solutions in the industry to meet EU AI Act requirements.

Marvin Assistant will be available with version 3.0.17 in January 2025, with further AI enhancements planned for later in the year.

Expanding the Chatbot Ecosystem
The Marvin Assistant is just the start. Similar chatbots for Dacima and Clindex will be introduced as part of EvidentIQ’s vision for AI-driven support across its product suite, boosting productivity and compliance.

Contact us for more information and/or download our Press Release

Hello, I'm Sabine Birkner

Marketing Manager

News

12 August 2024

EvidentIQ Germany Awarded Platinum Pharma Supplier Certification by Qualifyze

Read more

News

2 March 2023

Meet us at ACDM in Barcelona

Read more

Marvin Update, News

3 August 2019

All About Marvin: The Story of XClinical

Read more
Copyright © EvidentIQ Germany GmbH. All Rights Reserved.
EvidentIQ Germany GmbH, formerly XClinical is part of the EvidentIQ Group along with Carenity, Dacima and Fortress Medical Systems.
Home